Leukemia Clinical Trials in Houston

Showing 621-640 of 1,657 trials

Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

NCT05264545

A 510k approved dental device for subjects requiring single or multiple tooth replacement with implants where immediate restoration/loading is preferred.

Partially Edentulous Maxilla or Mandible

McGuire Institute100 participantsStarted Mar 2022

Aurora, Colorado, United States • Broomfield, Colorado, United States • Oakbrook Terrace, Illinois, United States +5 more locations

Active Not RecruitingPhase 1/2< 1 mile

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

NCT04730258

The purpose of this study is to test the safety of an investigational drug called CFI-400945 alone and in combination with azacitidine.

Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia+3 more

Treadwell Therapeutics, Inc72 participantsStarted Apr 2021

Duarte, California, United States • Sacramento, California, United States • Louisville, Kentucky, United States +6 more locations

Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

Leukemia Trials in Other Cities

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

A Study of SEA-CD40 Given With Other Drugs in Cancers

Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma

Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

Tempus Priority Study: A Pan-tumor Observational Study

RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

Study of REM-422 in Patients With AML or Higher Risk MDS

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

A Study of DM001 in Patients With Advanced Solid Tumors

A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer

Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Hairy Cell Leukemia Patient Data Registry

A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

Other Conditions in Houston